List of Chapters/Sections(Table Of Content)
1 Veterinary Drug Market Overview
1.1 Product Overview and Scope of Veterinary Drug
1.2 Veterinary Drug Segment by Type
1.2.1 Global Veterinary Drug Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Anti-Infectives
1.2.3 Anti-Inflammatory
1.2.4 Parasiticides
1.2.5 Analgesics
1.2.6 Sedatives
1.2.7 Others
1.3 Veterinary Drug Segment by Application
1.3.1 Global Veterinary Drug Sales Comparison by Application: (2021-2027)
1.3.2 Pets
1.3.3 Cattle
1.3.4 Poultry
1.3.5 Swine
1.3.6 Others
1.4 Global Veterinary Drug Market Size Estimates and Forecasts
1.4.1 Global Veterinary Drug Revenue 2016-2027
1.4.2 Global Veterinary Drug Sales 2016-2027
1.4.3 Veterinary Drug Market Size by Region: 2016 Versus 2021 Versus 2027
2 Veterinary Drug Market Competition by Manufacturers
2.1 Global Veterinary Drug Sales Market Share by Manufacturers (2016-2021)
2.2 Global Veterinary Drug Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Veterinary Drug Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Veterinary Drug Manufacturing Sites, Area Served, Product Type
2.5 Veterinary Drug Market Competitive Situation and Trends
2.5.1 Veterinary Drug Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Veterinary Drug Players Market Share by Revenue
2.5.3 Global Veterinary Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Veterinary Drug Retrospective Market Scenario by Region
3.1 Global Veterinary Drug Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Veterinary Drug Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Veterinary Drug Market Facts & Figures by Country
3.3.1 North America Veterinary Drug Sales by Country
3.3.2 North America Veterinary Drug Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Veterinary Drug Market Facts & Figures by Country
3.4.1 Europe Veterinary Drug Sales by Country
3.4.2 Europe Veterinary Drug Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Veterinary Drug Market Facts & Figures by Region
3.5.1 Asia Pacific Veterinary Drug Sales by Region
3.5.2 Asia Pacific Veterinary Drug Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Veterinary Drug Market Facts & Figures by Country
3.6.1 Latin America Veterinary Drug Sales by Country
3.6.2 Latin America Veterinary Drug Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Veterinary Drug Market Facts & Figures by Country
3.7.1 Middle East and Africa Veterinary Drug Sales by Country
3.7.2 Middle East and Africa Veterinary Drug Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Veterinary Drug Historic Market Analysis by Type
4.1 Global Veterinary Drug Sales Market Share by Type (2016-2021)
4.2 Global Veterinary Drug Revenue Market Share by Type (2016-2021)
4.3 Global Veterinary Drug Price by Type (2016-2021)
5 Global Veterinary Drug Historic Market Analysis by Application
5.1 Global Veterinary Drug Sales Market Share by Application (2016-2021)
5.2 Global Veterinary Drug Revenue Market Share by Application (2016-2021)
5.3 Global Veterinary Drug Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Zoetis
6.1.1 Zoetis Corporation Information
6.1.2 Zoetis Description and Business Overview
6.1.3 Zoetis Veterinary Drug Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Zoetis Veterinary Drug Product Portfolio
6.1.5 Zoetis Recent Developments/Updates
6.2 Elanco
6.2.1 Elanco Corporation Information
6.2.2 Elanco Description and Business Overview
6.2.3 Elanco Veterinary Drug Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Elanco Veterinary Drug Product Portfolio
6.2.5 Elanco Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Corporation Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Veterinary Drug Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Boehringer Ingelheim Veterinary Drug Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Merck
6.4.1 Merck Corporation Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck Veterinary Drug Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Merck Veterinary Drug Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 Virbac
6.5.1 Virbac Corporation Information
6.5.2 Virbac Description and Business Overview
6.5.3 Virbac Veterinary Drug Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Virbac Veterinary Drug Product Portfolio
6.5.5 Virbac Recent Developments/Updates
6.6 Ceva
6.6.1 Ceva Corporation Information
6.6.2 Ceva Description and Business Overview
6.6.3 Ceva Veterinary Drug Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Ceva Veterinary Drug Product Portfolio
6.6.5 Ceva Recent Developments/Updates
6.7 Vetoquinol
6.6.1 Vetoquinol Corporation Information
6.6.2 Vetoquinol Description and Business Overview
6.6.3 Vetoquinol Veterinary Drug Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Vetoquinol Veterinary Drug Product Portfolio
6.7.5 Vetoquinol Recent Developments/Updates
6.8 Dechra
6.8.1 Dechra Corporation Information
6.8.2 Dechra Description and Business Overview
6.8.3 Dechra Veterinary Drug Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Dechra Veterinary Drug Product Portfolio
6.8.5 Dechra Recent Developments/Updates
6.9 Norbrook
6.9.1 Norbrook Corporation Information
6.9.2 Norbrook Description and Business Overview
6.9.3 Norbrook Veterinary Drug Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Norbrook Veterinary Drug Product Portfolio
6.9.5 Norbrook Recent Developments/Updates
6.10 Phibro
6.10.1 Phibro Corporation Information
6.10.2 Phibro Description and Business Overview
6.10.3 Phibro Veterinary Drug Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Phibro Veterinary Drug Product Portfolio
6.10.5 Phibro Recent Developments/Updates
6.11 Huvepharma
6.11.1 Huvepharma Corporation Information
6.11.2 Huvepharma Veterinary Drug Description and Business Overview
6.11.3 Huvepharma Veterinary Drug Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Huvepharma Veterinary Drug Product Portfolio
6.11.5 Huvepharma Recent Developments/Updates
6.12 Hipra
6.12.1 Hipra Corporation Information
6.12.2 Hipra Veterinary Drug Description and Business Overview
6.12.3 Hipra Veterinary Drug Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Hipra Veterinary Drug Product Portfolio
6.12.5 Hipra Recent Developments/Updates
6.13 Ouro Fino Saude
6.13.1 Ouro Fino Saude Corporation Information
6.13.2 Ouro Fino Saude Veterinary Drug Description and Business Overview
6.13.3 Ouro Fino Saude Veterinary Drug Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Ouro Fino Saude Veterinary Drug Product Portfolio
6.13.5 Ouro Fino Saude Recent Developments/Updates
6.14 CAHIC
6.14.1 CAHIC Corporation Information
6.14.2 CAHIC Veterinary Drug Description and Business Overview
6.14.3 CAHIC Veterinary Drug Sales, Revenue and Gross Margin (2016-2021)
6.14.4 CAHIC Veterinary Drug Product Portfolio
6.14.5 CAHIC Recent Developments/Updates
6.15 Orion
6.15.1 Orion Corporation Information
6.15.2 Orion Veterinary Drug Description and Business Overview
6.15.3 Orion Veterinary Drug Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Orion Veterinary Drug Product Portfolio
6.15.5 Orion Recent Developments/Updates
6.16 Ringpu Biology
6.16.1 Ringpu Biology Corporation Information
6.16.2 Ringpu Biology Veterinary Drug Description and Business Overview
6.16.3 Ringpu Biology Veterinary Drug Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Ringpu Biology Veterinary Drug Product Portfolio
6.16.5 Ringpu Biology Recent Developments/Updates
6.17 Nippon Zenyaku Kogyo
6.17.1 Nippon Zenyaku Kogyo Corporation Information
6.17.2 Nippon Zenyaku Kogyo Veterinary Drug Description and Business Overview
6.17.3 Nippon Zenyaku Kogyo Veterinary Drug Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Nippon Zenyaku Kogyo Veterinary Drug Product Portfolio
6.17.5 Nippon Zenyaku Kogyo Recent Developments/Updates
6.18 Farmavet-Pasteur
6.18.1 Farmavet-Pasteur Corporation Information
6.18.2 Farmavet-Pasteur Veterinary Drug Description and Business Overview
6.18.3 Farmavet-Pasteur Veterinary Drug Sales, Revenue and Gross Margin (2016-2021)
6.18.4 Farmavet-Pasteur Veterinary Drug Product Portfolio
6.18.5 Farmavet-Pasteur Recent Developments/Updates
7 Veterinary Drug Manufacturing Cost Analysis
7.1 Veterinary Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Veterinary Drug
7.4 Veterinary Drug Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Veterinary Drug Distributors List
8.3 Veterinary Drug Customers
9 Veterinary Drug Market Dynamics
9.1 Veterinary Drug Industry Trends
9.2 Veterinary Drug Growth Drivers
9.3 Veterinary Drug Market Challenges
9.4 Veterinary Drug Market Restraints
10 Global Market Forecast
10.1 Veterinary Drug Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Veterinary Drug by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Veterinary Drug by Type (2022-2027)
10.2 Veterinary Drug Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Veterinary Drug by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Veterinary Drug by Application (2022-2027)
10.3 Veterinary Drug Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Veterinary Drug by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Veterinary Drug by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
